Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review

• Type: Another Publication in an International Scientific Journal
• Date: 2012

Authors

Abrantes, J (Author) Other; van der Loo, W (Author) Other; Le Pendu, J (Author) Other; Esteves, PJ (Author) Other

Journal

Title: Veterinary Research

Vol. 43

Final page: 12

ISSN: 0928-4249

Publisher: Springer Nature

Indexing

ISI Web of Knowledge - 315 Citations

Scopus - 342 Citations

Other information

Authenticus ID: P-002-D2F

DOI: 10.1186/1297-9716-43-12

Abstract (EN): Rabbit haemorrhagic disease virus (RHDV) is a calicivirus of the genus Lagovirus that causes rabbit haemorrhagic disease (RHD) in adult European rabbits (Oryctolagus cuniculus). First described in China in 1984, the virus rapidly spread worldwide and is nowadays considered as endemic in several countries. In Australia and New Zealand where rabbits are pests, RHDV was purposely introduced for rabbit biocontrol. Factors that may have precipitated RHD emergence remain unclear, but non-pathogenic strains seem to pre-date the appearance of the pathogenic strains suggesting a key role for the comprehension of the virus origins. All pathogenic strains are classified within one single serotype, but two subtypes are recognised, RHDV and RHDVa. RHD causes high mortality in both domestic and wild adult animals, with individuals succumbing between 48-72 h post-infection. No other species has been reported to be fatally susceptible to RHD. The disease is characterised by acute necrotising hepatitis, but haemorrhages may also be found in other organs, in particular the lungs, heart, and kidneys due to disseminated intravascular coagulation. Resistance to the disease might be explained in part by genetically determined absence or weak expression of attachment factors, but humoral immunity is also important. Disease control in rabbitries relies mainly on vaccination and biosecurity measures. Such measures are difficult to be implemented in wild populations. More recent research has indicated that RHDV might be used as a molecular tool for therapeutic applications. Although the study of RHDV and RHD has been hampered by the lack of an appropriate cell culture system for the virus, several aspects of the replication, epizootology, epidemiology and evolution have been disclosed. This review provides a broad coverage and description of the current knowledge on the disease and the virus.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 19